Jorge Crespo Carrillo, MD
Urology · Rio Piedras, PRNPI 1134311483
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $42,000 of the $61,915 with a category attached, or 67.8%. Verity Pharmaceuticals Inc. accounts for 95.7% of it on its own, with 10 other manufacturers making up the rest. Among urology clinicians in PR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 41 payments — averaging $1510.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Verity Pharmaceuticals Inc.$59K
- Boston Scientific$1K
- Travere Therapeutics, Inc.$366
- Neotract Inc.$199
- Teleflex LLC$177
- Merck$124
- plus $488 from 5 others
What the payments were for
- Consulting fees$17,00027%
- Speaking & faculty fees$42,00068%
- Food & beverage$2,9155%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Verity Pharmaceuticals Inc. | 14 | $59,277 |
| Boston Scientific | 12 | $1,282 |
| Travere Therapeutics, Inc. | 4 | $366 |
| Neotract Inc. | 2 | $199 |
| Teleflex LLC | 2 | $177 |
| Merck | 1 | $124 |
| Progenics Pharmaceuticals, Inc. | 1 | $124 |
| Urogen Pharma, Inc. | 1 | $114 |
| Pfizer | 1 | $100 |
| Olympus Latin America, Inc. | 1 | $100 |
| AbbVie | 2 | $50 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRELSTAR$59,245
- GENERAL BPH$256
- UroLift$251
- (815) Thiola$249
- REZUM$206
- AMS 700 CXR RTE KIT$139
- GENERAL KIDNEY STONE DISEASE$130
- GENERAL - THERAPIES$125
- KEYTRUDA$124
- PYLARIFY$124
- JELMYTO$114
- XTANDI$100
How this compares
$61,915 in reported general payments places this provider in the 95th percentile of 122 urology providers in Puerto Rico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 537 | $8,879 |
| Bicalutamide | 176 | $6,054 |
| Finasteride | 329 | $5,758 |
| Tolterodine Tartrate ErTolterodine Tartrate | 21 | $2,410 |
| Oxybutynin Chloride ErOxybutynin Chloride | 21 | $787 |
| Sildenafil Citrate | 30 | $508 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 20 | $467 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 13 | $315 |
| Ciprofloxacin Hcl | 14 | $115 |
| Tadalafil | 18 | $114 |
| Fluconazole | 11 | $69 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 18 | $61 |
Paid to pharmacies, not to this prescriber.
Other urology in Rio Piedras
- Luis AmbertRio Piedras$64K
- Claudio Bernaschina BobadillaPonce$132K
- Mariela Martinez-RiveraPonce$105K
- Freddy Mendez TorresCayey$95K
- Ronald Cadillo ChavezBayamon$61K
- Andres Perez RomanSan Juan$58K
- Rafael Bouet BlasiniSan Juan$55K
- Antonio Yulian ValentinCaguas$48K
- Alberto Ramirez LopezDorado$47K
- Jose Saavedra-BelaundeSan Juan$45K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.